Subscribe to our Newsletters !!
Eliminating sticker residue is a small yet frustra
Recent advances in precision science have abandone
The Nobel Prize in Physiology or Medicine awarded
Giesen, Germany. 26 January 2026 - At Interpack 20
Alembic Pharmaceuticals Limited (Alembic) today an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Micro
Dr Reddy’s Laboratories on August 19 announced the launch of Avigan (Favipiravir) pills, used for treating mild to moderate COVID-19 sufferers in India.
Dr Reddy’s stated Avigan was approved by the Drugs Controller General of India (DCGI) for treating patients with moderate to medium COVID-19.
“The need for high efficacy and quality, affordability and improved disease control are essential priorities for us. We think that Avigan would offer an effective treatment alternative to the COVID-19 affected sufferers in India,” M Ramana, CEO, Branded Markets (India and Emerging Markets), Dr Reddy’s Laboratories, stated.
